Kura Oncology
Melissa Yang currently serves as the Associate Director of Clinical Systems at Kura Oncology, Inc. since July 2025. Prior to this role, Melissa held the position of Senior Manager of Clinical Trials Systems in Clinical Operations and Data Management at Foundation Medicine from January 2021 to July 2025. Experience also includes working as a Lead Consultant and Consultant in Organizational Solutions at Halloran Consulting Group, Inc., and project management roles at Corbus Pharmaceuticals, including Computer Software Validation Project Manager and Clinical Systems Project Manager. Previous positions include Clinical Trial Assistant II at Merit Medical Systems, Medical Scribe at Brown Emergency Medicine, and Undergraduate Intern at Brown University. Melissa is pursuing an MBA at Questrom School of Business, Boston University, and a Master of Studies in Law focusing on Health Law & Policy at Wake Forest University School of Law, while holding a Bachelor of Arts degree from Rhode Island College.
This person is not in any teams
This person is not in any offices
Kura Oncology
21 followers
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment.